One hypothesis to explain this phenomenon is that blocking the TGF-β cascade in osteosarcoma cells inhibits the expression and secretion of the TGF-β target genes, such as RANKL and IL-11, which stimulate osteoclast activity (50). Here, IL11 is linked to osteosarcoma.